New male contraceptives promise greater family planning options
Summary and headline written by AI from the source article. How we work
Researchers at NEXT Life Sciences in Greece are developing new methods of male contraception, aiming to expand options beyond condoms and vasectomy.
For decades, men have had limited choices for preventing pregnancy. The company is working on two non-hormonal products. PausePill, a daily or on-demand pill, and Plan A, a long-term, reversible hydrogel implant, to address this gap. PausePill works by blocking the signal that causes sperm release, without affecting erection or orgasm, and early users report enhanced sexual enjoyment.
Plan A functions as a filter within the vas deferens, blocking sperm for years without interrupting fluid flow. A 2024 global poll of 18,000 men across seven countries revealed that 61% would try a new male contraceptive within a year of its release. More than 50,000 men have already signed up for waiting lists based on word of mouth, even though both products are still in clinical trials and require final health authority approval.
